Kendrick Lamar’s GNX has reclaimed its place at the top of the Billboard 200, securing a third non-consecutive week as the No ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.